Tranexamic Acid and Vitamin K Injection for Upper Gastrointestinal Bleeding in Cirrhotic Patients

This study focuses on understanding how effective Tranexamic acid and Vitamin K injections are compared to a placebo in controlling upper gastrointestinal bleeding in Egyptian patients with liver cirrhosis. The study is particularly relevant as these patients often face such bleeding due to their condition, and finding an effective treatment could significantly improve their health outcomes. The research aims to determine if this combination can reduce bleeding and lower the risk of death in these patients more effectively than current standard practices. Participants in the study are divided into two groups, one receiving the Tranexamic acid and Vitamin K injections, and the other receiving a placebo, which is an inactive treatment. The treatment involves an initial dose of Tranexamic acid, followed by a maintenance dose, alongside Vitamin K injections, while the placebo group receives saline solutions. The study evaluates the patients' bleeding rates and mortality over a period of 5 days and again after 6 weeks. It also looks at other important factors like the need for blood transfusions, length of hospital stay, and any side effects experienced. To ensure safety, all participants receive standard care including medications and endoscopy, and their progress is closely monitored.